Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.7M
-
Number of holders
-
261
-
Total 13F shares, excl. options
-
30.1M
-
Shares change
-
-1.45M
-
Total reported value, excl. options
-
$3.24B
-
Value change
-
-$146M
-
Put/Call ratio
-
1.4
-
Number of buys
-
148
-
Number of sells
-
-111
-
Price
-
$107.74
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q3 2025
319 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q3 2025.
GeneDx Holdings Corp. - Common Stock (WGS) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.1M shares
.
Largest 10 shareholders include Corvex Management LP (3.06M shares), Casdin Capital, LLC (3.01M shares), BlackRock, Inc. (1.53M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.22M shares), VANGUARD GROUP INC (1.17M shares), GOLDMAN SACHS GROUP INC (1.17M shares), ORACLE INVESTMENT MANAGEMENT INC (890K shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (824K shares), T. Rowe Price Investment Management, Inc. (718K shares), and FRANKLIN RESOURCES INC (681K shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.